Geratherm Medical Forecast, price target & analysts
Geratherm Medical Target price 2026 - Analyst rating & recommendation
Geratherm Medical Classifications & Recommendation
Geratherm Medical Price Target
| Target Price | €4.08 |
| Price | €2.17 |
| Potential |
88.02%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Geratherm Medical 2027 .
The average Geratherm Medical target price is €4.08.
This is
88.02%
register free of charge
€4.20
93.55%
register free of charge
€4.04
86.18%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Geratherm Medical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Geratherm Medical stock has an average upside potential 2027 of
88.02%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 14.87 | 14.65 |
| 6.37% | 1.51% | |
| EBITDA Margin | 1.61% | 8.28% |
| 93.26% | 413.02% | |
| Net Margin | -5.51% | -2.24% |
| 208.58% | 59.38% |
2 Analysts have issued a sales forecast Geratherm Medical 2026 . The average Geratherm Medical sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Geratherm Medical EBITDA forecast 2026. The average Geratherm Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Geratherm Medical Analysts have issued a net profit forecast 2026. The average Geratherm Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | -0.15 | -0.06 |
| 215.38% | 60.00% | |
| P/E | negative | |
| EV/Sales | 0.37 |
2 Analysts have issued a Geratherm Medical forecast for earnings per share. The average Geratherm Medical EPS is
This results in the following potential growth metrics and future valuations:
Geratherm Medical...
Current Geratherm Medical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Sep 01 2026 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Jun 12 2026 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Jun 11 2026 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Jan 16 2026 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Aug 29 2025 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Jun 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Sep 01 2026 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Jun 12 2026 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Jun 11 2026 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Jan 16 2026 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Aug 29 2025 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Jun 04 2025 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Jun 03 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
